Canandaigua National Bank & Trust CO Gsk PLC Transaction History

Canandaigua National Bank & Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	SELL	$33.5 - $36.43 $270,814 - $294,500	-8,084 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $90,751 - $97,615	2,243 Added 38.4%	8,084 $345,000
Q1 2019 Apr 25, 2019	SELL	$38.57 - $42.69 $38 - $42	-1 Reduced 0.02%	5,841 $244,000
Q3 2018 Nov 02, 2018	SELL	$39.75 - $42.69 $30,289 - $32,529	-762 Reduced 11.54%	5,842 $235,000
Q2 2018 Aug 03, 2018	BUY	$39.61 - $42.76 $4,475 - $4,831	113 Added 1.74%	6,604 $266,000
Q1 2018 May 09, 2018	BUY	$36.18 - $40.15 $234,844 - $260,613	6,491 New	6,491 $254,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $75.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.